Volume : 10, Issue : 08, August – 2023

Title:

14.PIPERACILLIN-TAZOBACTAM INDUCED THROMBOCYTOPENIA: A CASE REPORT
‬

Authors :

Khawaja Talha Aziz , Malik Hasnat ul Hassan Khan, Javed Miandad, Mohammad Saad Waqas, Syed Aftab Ahmed

Abstract :

Drug-induced thrombocytopenia is a common cause of thrombocytopenia and a long list of drugs are implicated in this phenomenon. There are at least 3 mechanisms implicated in drug-induced thrombocytopenia; bone marrow suppression, immunological and non-immunological thrombocytopenia. We present here a case of a young adult female presenting with a perinephric abscess who was started on broad-spectrum piperacillin-tazobactam. On day 12 of the starting antibiotics there was an abrupt and thereafter rapid decline in her platelet count. After a thorough investigation to rule out other possible causes of thrombocytopenia, drug-induced thrombocytopenia as a possible etiology was suspected. Subsequently, the antibiotic was withheld after a discussion with the hospital hematologist and a blood picture repeated daily thereafter showed a rapid increase in platelet count once the offending agent was withdrawn. The patient thereafter was started on a different class of antibiotic and had a complete recovery and was discharged after a prolonged stay of 33 days..

Cite This Article:

Please cite this article in press Khawaja Talha Aziz et al, Piperacillin-Tazobactam Induced Thrombocytopenia: A Case Report, Indo Am. J. P. Sci, 2023; 10 (08).

Number of Downloads : 10

References:

1. Smock KJ, Perkins SL. (2014). Thrombocytopenia: an update. International Journal of Laboratory Hematology, 36(3), 269-278.
2. Arnold DM, Lim W. (2011). A rational approach to the diagnosis and management of thrombocytopenia in the hospitalized patient. Seminars in Hematology, 48(4), 251-258.
3. Harker LA, Finch CA. (1969). Thrombokinetics in man. Journal of Clinical Investigation, 48(6), 963-974.
4. Bougie DW, Wilker PR, Aster RH. (2006). Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug-specific” antibodies. Blood, 108(3), 922-927.
5. Aster RH. (1999). Drug-induced immune thrombocytopenia: an overview of pathogenesis. Seminars in Hematology, 36(1 Suppl 1), 2-6.
6. Fekete GL, Fekete L, Ancuceanu R, Ianoși SL, Drăgănescu M, & Brihan I. (2020). Acyclovir induced immune thrombocytopenia: Case report and review of the literature. Experimental and Therapeutic Medicine, 20, 3417-3420.
7. Aster RH, Curtis BR, McFarland JG, & Bougie DW. (2009). Drug-induced immune thrombocytopenia: Pathogenesis, diagnosis, and management. Journal of Thrombosis and Haemostasis, 7, 911-918.
8. Piperacillin–tazobactam induced cytopenia in low cumulative treatment doses | BMJ Case Reports
9. Macwilliam JL, Mistry R, Floyd MS Jr, and Baird AD: Piperacillin/tazobactam-induced thrombocytopenia – a delayed response. BMJ Case Rep. 2012. View Article: Google Scholar: PubMed/NCBI
10. Shaik S, Kazi HA, and Ender PT: Rapid-onset piperacillin-tazobactam induced thrombocytopenia. J Pharm Pract. 28:204–206. 2015. View Article: Google Scholar: PubMed/NCBI
11. Ruiz-Irastorza G, Barreiro G, and Aguirre C: Reversible bone marrow depression by high-dose piperacillin/tazobactam. Br J Haematol. 95:611–612. 1996. View Article: Google Scholar: PubMed/NCBI
12. Kumar A, Choudhuri G, and Aggarwal R: Piperacillin induced bone marrow suppression: A case report. BMC Clin Pharmacol. 3:22003. View Article: Google Scholar: PubMed/NCBI
13. Pérez-Vázquez A, Pastor JM, and Riancho JA: Immune thrombocytopenia caused by piperacillin/tazobactam. Clin Infect Dis. 27:650–651. 1998. View Article: Google Scholar: PubMed/NCBI
14. Grégoire C, Brumpt C, Loirat D, Lau N, Bruel C, Philippart F, Couzigou C, Garrouste-Orgeas M, and Misset B: A case of daptomycin-induced immune thrombocytopenia. Antimicrob Agents Chemother. 56:6430–6431. 2012. View Article: Google Scholar: PubMed/NCBI